The two are hot topics, but how do they combine in the arena of HIV? That's what two lectures at Grand Valley State University's Allendale Campus will explore on April 13. The first lecture is by ...

The conference emphasized advancements in HIV pathogenesis, persistence, and gene therapy, alongside policy and drug use intersections. Lenacapavir was found safe in adolescents, offering new insights ...

Vaccine development remains central to reducing incident HIV globally, particularly where long-acting PrEP access is limited, with therapeutic and preventive approaches advancing in parallel.

Overall, the story of HIV is one of astounding success. But to declare victory, it will be necessary to develop a vaccine. The opening session of the 31st Conference on Retroviruses and Opportunistic ...

Dr. Anthony Fauci detailed his extensive career leading the U.S. through multiple health crises in his role as the director of the National Institute of Allergy and Infectious Diseases and emphasized ...